Trial Profile
Observational (non-interventional), follow-up trial assessing long-term local tolerability and efficacy (recurrence rate) of resiquimod gel in patients treated for actinic keratosis. [Beobachtende Folgestudie um die Langzeit-Verträglichkeit und Wirksamkeit (Häufigkeit des Wiederauftretens von AK-Läsionen) von Resiquimod Gel bei Patienten mit aktinischer Keratose, die zuvor mit Resiquimod Gel behandelt wurden, zu untersuchen. [Erweiterungsversuch zum klinischen Versuch SP848AK1101]] [EXTENSION OF 700216015]
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2016
Price :
$35
*
At a glance
- Drugs Resiquimod (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 24 Oct 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 May 2013 Planned end date changed from 1 Apr 2015 to 1 Aug 2015 as reported by ClinicalTrials.gov.
- 06 Mar 2013 Planned End Date (Apr 2015) added as reported by ClinicalTrials.gov.